Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease proteinuria
Phenotype C0017665|membranous nephropathy
Sentences 9
PubMedID- PMC3991017 However, it has not been reported in non-diabetic ckd and its role in residual proteinuria in patients with membranous nephropathy is unclear.
PubMedID- 24886340 Remission of proteinuria in patients with idiopathic membranous nephropathy and nephrotic syndrome according to fe-igg level.
PubMedID- 26087670 Rituximab, a monoclonal antibody that specifically targets cd20 on the surface of b-cells, is effective in achieving a complete remission of proteinuria in patients with idiopathic membranous nephropathy.
PubMedID- 24174881 Acthar® gel (acthar; questcor pharmaceuticals, inc., union city, ca, usa) has recently been shown to induce remission, defined as stabilization or improvement of renal function (by estimated glomerular filtration rate) and resolution of proteinuria, in patients with idiopathic membranous nephropathy.7 herein, we describe a case in which 13 months of treatment with acthar resulted in a sustained remission of membranous nephropathy in a patient with refractory disease.
PubMedID- 23560927 In addition astragalus membranaceus has been shown to improve patients’ proteinuria with idiopathic membranous nephropathy [13,14].
PubMedID- 26558120 He also had prior nephrotic range proteinuria documented with secondary membranous nephropathy of unspecified etiology.
PubMedID- 23439390 [16] its expression was reported to be associated with early electron microscopic alterations of the podocytes and heavy proteinuria in patients with idiopathic membranous nephropathy.
PubMedID- 23814426 [1] proteinuria is usually associated with membranous nephropathy, and it is rarely associated with minimal change disease or mesangioproliferative glomerulonephritis.
PubMedID- 23815417 Background: idiopathic membranous nephropathy (imn) patients with persistent high-grade proteinuria are at the highest risk for developing end-stage renal failure.

Page: 1